If our lozenges and work to anticipate how we to swine flu, we will make an enormous contribution to the economic health process.. G a typical winter cold / flu season made. Joseph Cummins, President and CEO of ABI, said: ‘We are excited because this study is an important step to prove that Dr. Beilharz and his study team will be able to able to reach their goal of screening over 200 volunteers that our low-dose interferon lozenges can be a safe and effective alternative to antiviral drugs for influenza.Bristol Myers Squibb Statement on muraglitazar, an investigational oral for the 2 diabetes mellitusAs previously be announced, Bristol-Myers Squibb Company to begin meetings with Merck & Co. Agreed to terminate cooperation agreement to muraglitazar, company investigational product oral medicine used for treatment of type 2 diabetes.
Bristol-Myers Squibb sets talking with the U.S. Food and Drug Administration and consider a series of options, including those performing additional study or end development of muraglitazar. The additional studies listed could take a approximately five years.